FDA approves Novartis' Tekamlo for treatment of high blood pressure
Links shared publicly online about this topic.
- 917total visits
FDA approves Novartis' Tekamlo for treatment of high blood pressure
View full resource at news-medical.net
Tags: Heart Disease, Angina Medication, High Blood Pressure, High Blood Pressure Medication, Drug, FDA, Calcium Channel Blocker
Most Recently Shared on August 27, 2010 at 5:27 pm By:
Pregnancy News: FDA approves Novartis' Tekamlo for treatment of high blood pressure: The US Food and Drug Administ... http://bit.ly/a1tO77
Also Shared By:
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
drugs.com — “Tekamlo (aliskiren and amlodipine) is used to treat high blood pressure. Includes Tekamlo side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 29, 2010 at 11:22 pm By:
FDA approves Tekamlo (aliskiren and amlodipine) to treat high blood pressure - http://bit.ly/cKmXHQ
Valturna approved for treatment of hypertension - MPR
empr.com — “The FDA has approved Valturna (aliskiren and valsartan tablets, from Novartis), a combination agent containing a direct renin inhibitor and an angiotensin receptor blocker, for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (ARB) monotherapy and as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.” View full resource at empr.com
Most Recently Shared on September 18, 2009 at 3:42 pm By:
MPR News: Valturna approved for treatment of hypertension: The FDA has approved Valturna (aliskiren and.. http://bit.ly/QLS85
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
novartis.com — “Basel, September 17, 2009 - The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure[2]. This is the first approval for Valturna, which is indicated for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (AR” View full resource at novartis.com
Most Recently Shared on September 18, 2009 at 7:52 am By:
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren http://twurl.nl/samel4
Advertisement
News-Medical.Net
@NewsMedical
FDA approves Novartis' Tekamlo for treatment of high blood pressure: The US Food and Drug Administration (FDA) app... http://bit.ly/a1tO77
1 year ago...